VOLITIONRX LTD — Form 8-K
Filed September 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
VolitionRx filed an 8-K on 2026-09-25 disclosing an unregistered sale of equity securities (Item 3.02) as of 2026-09-22. The filing provides no concrete details: no counterparty name, dollar amount, share count, price per share, or discount percentage are disclosed in the available text. The substantive terms of the transaction cannot be assessed from this filing extract.
Why this rating
Without material transaction details (size, terms, dilution %), cannot assess impact. Routine disclosure of unregistered equity transaction relative to ~$73M market cap.
Extracted items
See more from September 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.